1342290-43-0

1342290-43-0 structure

1342290-43-0 structure

Name: Abrilumab
Chemical Name: Abrilumab
CAS Number: 1342290-43-0
Molecular Formula:
Molecular Weight:
Catalog: Signaling Pathways Cytoskeleton Integrin
Create Date: 2022-10-12 18:40:11
Modify Date: 2024-04-14 03:16:29
Abrilumab is a fully human monoclonal antibody directed against α4β7. Abrilumab selectively binds the α4β7 integrin heterodimer. Abrilumab can be used for the research of inflammatory bowel disease (IBD)[1].

Name	Abrilumab

Description	Abrilumab is a fully human monoclonal antibody directed against α4β7. Abrilumab selectively binds the α4β7 integrin heterodimer. Abrilumab can be used for the research of inflammatory bowel disease (IBD)[1].
Related Catalog	Research Areas >> Cancer Research Areas >> Infection Research Areas >> Inflammation/Immunology Signaling Pathways >> Cytoskeleton >> Integrin
References	[1]. Iris Dotan, et al. The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies. Med Res Rev [2]. Christopher A Lamb, et al. Gut-Selective Integrin-Targeted Therapies for Inflammatory Bowel Disease. J Crohns Colitis. 2018 Aug 22;12(suppl_2):S653-S668.

No Any Chemical & Physical Properties